中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2014年
22期
1446-1449
,共4页
胡芸%金朝林%王翔%张树桐%谢元亮%李惠
鬍蕓%金朝林%王翔%張樹桐%謝元亮%李惠
호예%금조림%왕상%장수동%사원량%리혜
乳腺癌%新辅助化疗%磁共振成像%动态增强扫描%肿瘤退缩模式
乳腺癌%新輔助化療%磁共振成像%動態增彊掃描%腫瘤退縮模式
유선암%신보조화료%자공진성상%동태증강소묘%종류퇴축모식
breast cancer%neo-adjuvant chemotherapy%MR imaging%dynamic contrast-enhanced imaging%tumor shrinking pattern
目的:探讨乳腺癌的磁共振强化方式与新辅助化疗后退缩模式间的相关性,及其指导制定手术方案的临床意义。方法:55例局部进展期乳腺癌患者分别于新辅助化疗前及全程化疗后手术前,行乳腺磁共振动态增强扫描,观察化疗前肿瘤的磁共振强化方式和化疗后肿瘤退缩模式,分析两者之间的相关性。结果:55例患者中54例为单乳病变、1例为双乳病变,共56处病灶。肿块样强化为24处(43%),其中23处呈向心性退缩、1处呈环形退缩(P<0.01);多灶肿块样强化为13处(23%),其中2处为单一肿块呈向心性退缩、11处退缩后仍呈多灶肿块(P<0.01);肿块伴周边非肿块样强化为8处(14%),其中4处呈向心性退缩、4处呈蜂窝状多灶退缩(P>0.05);非肿块样强化为11处(20%),其中4处呈向心性退缩、7处呈蜂窝状多灶退缩(P<0.01)。结论:新辅助化疗后肿瘤的退缩模式是保乳手术选择的关键因素之一,根据乳腺癌在新辅助化疗前的磁共振动态增强强化方式,可在一定程度上预测其在化疗后的退缩模式,进而预测患者保乳手术的可行性,为临床医生选择个体化的后续治疗方案提高患者生存质量提供参考。
目的:探討乳腺癌的磁共振彊化方式與新輔助化療後退縮模式間的相關性,及其指導製定手術方案的臨床意義。方法:55例跼部進展期乳腺癌患者分彆于新輔助化療前及全程化療後手術前,行乳腺磁共振動態增彊掃描,觀察化療前腫瘤的磁共振彊化方式和化療後腫瘤退縮模式,分析兩者之間的相關性。結果:55例患者中54例為單乳病變、1例為雙乳病變,共56處病竈。腫塊樣彊化為24處(43%),其中23處呈嚮心性退縮、1處呈環形退縮(P<0.01);多竈腫塊樣彊化為13處(23%),其中2處為單一腫塊呈嚮心性退縮、11處退縮後仍呈多竈腫塊(P<0.01);腫塊伴週邊非腫塊樣彊化為8處(14%),其中4處呈嚮心性退縮、4處呈蜂窩狀多竈退縮(P>0.05);非腫塊樣彊化為11處(20%),其中4處呈嚮心性退縮、7處呈蜂窩狀多竈退縮(P<0.01)。結論:新輔助化療後腫瘤的退縮模式是保乳手術選擇的關鍵因素之一,根據乳腺癌在新輔助化療前的磁共振動態增彊彊化方式,可在一定程度上預測其在化療後的退縮模式,進而預測患者保乳手術的可行性,為臨床醫生選擇箇體化的後續治療方案提高患者生存質量提供參攷。
목적:탐토유선암적자공진강화방식여신보조화료후퇴축모식간적상관성,급기지도제정수술방안적림상의의。방법:55례국부진전기유선암환자분별우신보조화료전급전정화료후수술전,행유선자공진동태증강소묘,관찰화료전종류적자공진강화방식화화료후종류퇴축모식,분석량자지간적상관성。결과:55례환자중54례위단유병변、1례위쌍유병변,공56처병조。종괴양강화위24처(43%),기중23처정향심성퇴축、1처정배형퇴축(P<0.01);다조종괴양강화위13처(23%),기중2처위단일종괴정향심성퇴축、11처퇴축후잉정다조종괴(P<0.01);종괴반주변비종괴양강화위8처(14%),기중4처정향심성퇴축、4처정봉와상다조퇴축(P>0.05);비종괴양강화위11처(20%),기중4처정향심성퇴축、7처정봉와상다조퇴축(P<0.01)。결론:신보조화료후종류적퇴축모식시보유수술선택적관건인소지일,근거유선암재신보조화료전적자공진동태증강강화방식,가재일정정도상예측기재화료후적퇴축모식,진이예측환자보유수술적가행성,위림상의생선택개체화적후속치료방안제고환자생존질량제공삼고。
Objective:To investigate the correlation between the breast cancer MRI schedule of reinforcement and the shrinkage pattern of tumor after neo-adjuvant chemotherapy, and its clinical significance in the guidance of formulating operation plan. Methods:Dynamic contrast-enhanced MRI scan was performed before chemotherapy and before surgery after a whole-range N-Acety-L-Cysteine (NAC) treatment in 55 patients with loco-regionally advanced breast cancer who received the neo-adjuvant chemotherapy. MRI sched-ule of reinforcement and the shrinkage pattern of tumor after neo-adjuvant chemotherapy were obtained in the treatment, and the corre-lation between the two was analyzed. Results:Of the 55 patients, the unilateral breast mass was found in 54 and the bilateral lesion in 1. There were 56 neo-plastic foci in these patients. The mass-like enhanced image was seen in 24 of the total cases (43%), of which 23 presented with a centripetal shrinkage, 1 with an annular decline, (P<0.01). Multifocal mass-like enhancement image was found in 13 of the total cases, (23%), of which 2 centripetal shrinkages were the singular mass, 11 remained a multifocal lesion after the tumor shrinkage (P<0.01). The mass with peripheral non-tumor-like enhancement image was seen in 8 of the total cases (14%), of which 4 showed a centripetal shrinkage and another 4 a honeycombed multifocal decline (P>0.05). There were 11 of the total cases with non-tu-mor-like enhancement (20%), in which 4 assumed a centripetal shrinkage and 7 a honeycombed multifocal shrinkage (P<0.01). Conclu-sion:The tumor shrinking pattern and its accurate radiological image evaluation are the keys to the selection of breast-conserving sur-gery and the control of local recurrence after treatment of NAC regimen. We can predict the shrinking pattern through the type of the le-sion on baseline before NAC, which is important for the patients and surgeon to get a reasonable expectation in the subsequent treat-ments.